Skip to main navigation menu Skip to main content Skip to site footer

Original article

Vol. 143 No. 2324 (2013)

Profiles of drug users in Switzerland and effects of early-onset intensive use of alcohol, tobacco and cannabis on other illicit drug use

  • Stéphanie Baggio
  • Joseph Studer
  • Meichun Mohler-Kuo
  • Jean-Bernard Daeppen
  • Gerhard Gmel
DOI
https://doi.org/10.4414/smw.2013.13805
Cite this as:
Swiss Med Wkly. 2013;143:w13805
Published
02.06.2013

Summary

QUESTIONS UNDER STUDY / PRINCIPLES: The main aim of this study was to investigate profiles of drug users, with a particular focus on illicit drugs other than cannabis, and to explore the effect of early-onset intensive use (drunkenness, daily smoking, high on cannabis) on profiles of illicit drug use.

METHODS: Baseline data from a representative sample of 5,831 young Swiss men in the ongoing Cohort Study on Substance Use Risk Factors were used. Substance use (alcohol, tobacco, cannabis and 15 types of other illicit drug) and age of onset of intensive use were assessed. The Item Response Theory (IRT) and prevalence rates at different ages of onset were used to reveal different profiles of illicit drug use.

RESULTS: In addition to cannabis, there were two profiles of other illicit drug use: (a) “softer” drug users (uppers, hallucinogens and inhaled drugs), among which ecstasy had the highest discriminatory potential (IRT slope = 4.68, standard error (SE) = 0.48; p <0.001); and (b) “harder” drug users (heroin, ketamine, gamma-hydroxybutyrate/gamma-hydroxylactone, research chemicals, crystal meth and spice), among which ketamine had the highest discriminatory potential (slope = 4.05; SE = 0.63; p <0.001). Onset of intensive use at the age of 12 years or younger also discriminated between these two profiles.

CONCLUSION: Both the IRT model and the effect of onset of intensive use enabled two groups of illicit drugs to be identified. In particular, very early onset (at 12 years or younger) intensive use of any substance was a marker for later use of the second group of drugs.

References

  1. Kandel DB. Stages in adolescent involvement in drug use. Science. 1975;190(4217):912–4.
  2. Kandel DB, Yamaguchi K. Stages of involvement in the U.S. population. Stages and pathways of drug involvement: Examining the gateway hypothesis. New York: Cambridge University Press; 2002. p. 65–89.
  3. Kandel DB, Yamaguchi K, Klein LC. Testing the Gateway Hypothesis. Addiction. 2006;101(4):470–2; discussion 4–6.
  4. Scholey AB, Parrott AB, Buchanan T, Heffernan TM, Ling J, Rodgers J. Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study. Addictive Behaviors. 2004;(29):743–52.
  5. Hamburg BA, Kraemer HC, Jahnke W. A hierarchy of drug use in adolescence: Behavioral and attitudinal correlates of substantial drug use. The American Journal of Psychiatry. 1975;132(11):1155–63.
  6. Fergusson DM, Boden JM, Horwood LJ. Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis. Addiction. 2006;101(4):556–69.
  7. Kandel DB. Examining the gateway hypothesis stages and pathways of drug involvement. Stages and pathways of drug involvement: Examining the gateway hypothesis. New York: Cambridge University press; 2002. p. 3–15.
  8. Wu L-T, Schlenger WE, Galvin DM. Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths. Drug Alcohol Depend. 2006;84(1):102–13.
  9. Pape H, Rossow I, Storvoll EE. Under double influence: Assessment of simultaneous alcohol and cannabis use in general youth populations. Drug Alcohol Depend. 2009;101(1–2):69–73.
  10. Pentz MA, Li C. The gateway theory applied to prevention. Stages and Pathways of Drug Involvement: Examining the Gateway Hypothesis. New York: Cambridge University Press; 2002. p. 139–57.
  11. Wagner FA, Anthony JC. Into the world of illegal drug use: Exposure opportunity and other mechanisms linking the use of alcohol, tobacco, marijuana, and cocaine. Am J Epidemiol. 2002;155(10):918–25.
  12. Willner P. A view through the gateway: expectancies as a possible pathway from alcohol to cannabis. Addiction. 2001;96(5):691–703.
  13. Kokkevi A, Richardson C, Florescu S, Kuzman M, Stergar E. Psychosocial correlates of substance use in adolescence: A cross-national study in six European countries. Drug Alcohol Depend. 2007;86(1):67–74.
  14. Goldstein JW, Gleason TC, Korn JH. Whither the Epidemic? Psychoactive Drug-Use Career Patterns of College Students1. Journal of Applied Social Psychology. 1975;5(1):16–33.
  15. Kaplan HB, Martin SS, Robbins C. Pathways to Adolescent Drug Use: Self-Derogation, Peer Influence, Weakening of Social Controls, and Early Substance Use. Journal of Health and Social Behavior. 1984;25(3):270–89.
  16. Valenzuela E, Fernández M. The sequence of drug use: Testing the Gateway Hypothesis in Latin America. The Journal of International Drug, Alcohol and Tobacco Research. 2011;1(1):1–8.
  17. Kandel DB, Yamaguchi K, Klein LC. Testing the Gateway Hypothesis. Addiction. 2006;101(4):470–2.
  18. Gross SR, Barrett SP, Shestowsky JS, Pihl RO. Ecstasy and drug consumption patterns: a Canadian rave population study. Canadian Journal of Psychiatry. 2002;47(6):546–51.
  19. Hays RD, Stacy AW, Widaman KF, Di Matteo MR, Downy R. Multistage path models of adolscent alcohol and drug use: A reanalysis. The Journal of Drug Issues. 1986;16:357–69.
  20. Windle M, Barnes GM, Welte J. Causal models of adolescent substance use: An examination of gender differences using distribution-free estimators. Journal of Personality and Social Psychology. 1989;56(1):132–42.
  21. Agrawal A, Neale MC, Prescott CA, Kendler KS. Cannabis and Other Illicit Drugs: Comorbid Use and Abuse/Dependence in Males and Females. Behavior Genetics. 2004;34(3):217–28.
  22. Kuntsche E, Rossow I, Simons-Morton B, Bogt TT, Kokkevi A, Godeau E. Not Early Drinking but Early Drunkenness Is a Risk Factor for Problem Behaviors Among Adolescents from 38 European and North American Countries. Alcoholism: Clinical and Experimental Research. 2013;37(2):308–14.
  23. Lynskey M, Vink J, Boomsma D. Early Onset Cannabis Use and Progression to other Drug Use in a Sample of Dutch Twins. Behavior Genetics. 2006;36(2):195–200.
  24. Hall W, Lynskey M. Is cannabis a gateway drug? Testing hypotheses about the relationship between cannabis use and the use of other illicit drugs. Drug and Alcohol Review. 2005;24(1):39–48.
  25. Mayet A, Legleye S, Falissard B, Chau N. Cannabis use stages as predictors of subsequent initiation with other illicit drugs among French adolescents: use of a multi-state model. Addict Behav. 2012;37(2):160–6.
  26. Guxens M, Nebot M, Ariza C. Age and sex differences in factors associated with the onset of cannabis use: a cohort study. Drug Alcohol Depend. 2007;88(2-3):234–43.
  27. Korhonen T, van Leeuwen AP, Reijneveld SA, Ormel J, Verhulst FC, Huizink AC. Externalizing behavior problems and cigarette smoking as predictors of cannabis use: the TRAILS Study. J Am Acad Child Adolesc Psychiatry. 2010;49(1):61–9.
  28. Guxens M, Nebot M, Ariza C, Ochoa D. Factors associated with the onset of cannabis use: a systematic review of cohort studies. Gac Sanit. 2007;21(3):252–60.
  29. Studer J, Baggio S, Mohler-Kuo M, Dermota P, Gaume J, Bertholet N, et al. Examining non-response bias in substance use research – Are late respondents proxies for non-respondents? Drug Alcohol Depend. Forthcoming 2013.
  30. Wright D, Sathe N. State estimates of substance use from the 2002-2003 National Surveys on Drug Use and Health. Rockville, MD: SAMHSA, Offoce of Applied Studies; 2005.
  31. Fergusson Dm HL. Early reactions to cannabis predict later dependence. Arch Gen Psychiatry. 2003;60(10):1033–9.
  32. Meier MH, Caspi A, Ambler A, Harrington H, Houts R, Keefe RSE, et al. Persistent cannabis users show neuropsychological decline from childhood to midlife. PNAS. Forthcoming 2013.
  33. Neal DJ, Corbin WR, Fromme K. Measurement of alcohol-related consequences among high school and college students: application of item response models to the Rutgers Alcohol Problem Index. Psychol Assess. 2006;18(4):402–14.
  34. Birnbaum A. Some latent trait models. Statistical theories of mental test scores. Reading, MA: Addison-Wesley Publishing company; 1968.
  35. Lord FM, Novick MR. Statistical Theories of Mental Test Scores. Reading, MA: Addison-Wesley Publishing Company, ; 1968.
  36. Golub A, Johnson BD. The Shifting Importance of Alcohol and Marijuana as Gateway Substances among Serious Drug Abusers. Journal of Studies on Alcohol and Drugs. 1994;55(5):607-14.
  37. Clinard MB, Meier RF. Sociology of Deviant Behavior. Fort worth, TX: Harcourt College Publishers; 2001.
  38. Kim S-H, Shanahan J. Stigmatizing smokers: public sentiment toward cigarette smoking and its relationship to smoking behaviors. J Health Commun. 2003;8(4):343–67.
  39. Grønkjaer M, Curtis T, Crespigny CD, Delmar C. Acceptance and expectance: Cultural norms for alcohol use in Denmark. Int J Qual Stud Health Well-being. 2011;6(4). doi: 10.3402/qhw.v6i4.8461. Epub 2011 Nov 3.
  40. NHMRC. Australian guidelines to reduce health risks from drinking alcohol. Canberra: NHMRC; 2009.
  41. Dryfoos JG. Adolescents ar risk. New York, BY, USA: Oxford University Press; 1990.
  42. Donovan JE, Jessor R. Structure of problem behavior in adolescence and young adulthood. J Consult Clin Psychol. 1985;53(6):890–904.
  43. EMCDDA. The state of the drugs problem in Europe. Lisbon: European Monitoring Center for Drugs and Drug Addiction; 2011.
  44. Choo T, Roh S, Robinson M. Assessing the “Gateway Hypothesis” among Middle and High School Students in Tennessee. Journal of Drug Issues. 2008;38(2):467–92.
  45. Leshner AI. Foreword. Stages and pathways of drug involvement: Examining the gateway hypothesis. New York: Cambridge University Press; 2002. p. xiii-xiv.
  46. Hawkins JD, Hill KG, Guo J, Battin-Pearson SR. Substance use norms and transitions in substance use. Stages and pathways of drug involvement: Examining the gateway hypothesis. New York: Cambridge University Press; 2002. p. 42–64.
  47. Mayet A, Legleye S, Chau N, Falissard B. Transitions between tobacco and cannabis use among adolescents: a multi-state modeling of progression from onset to daily use. Addict Behav. 2011;36(11):1101–5.
  48. Mackesy-Amiti ME, Fendrich M, Goldstein PJ. Sequence of drug use among serious drug users: typical vs atypical progression. Drug Alcohol Depend. 1997;45(3):185–96.
  49. Labouvie E, White. Drug sequences, age of onset, and use trajectories as predictors of drug abuse/dependence in young adulthood. Stages and Pathways of Drug Involvement: Examining the Gateway Hypothesis. New York: Cambridge University Press; 2002. p. 19–41.

Most read articles by the same author(s)

1 2 > >>